Buyout bosses intend to contest any attempt by competition watchdog to disqualify them as directors of British companies ...

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a ...

On August 7, 2025, the Food and Drug Administration announced that it would be demanding the elimination of natural thyroid treatment, otherwise known as desiccated thyroid extract (DTE) or natural ...

BBP-418 hit the mark in the phase 3 FORTIFY trial by achieving a significant increase in glycosylated alpha-dystroglycan (αDG ...

Police walk past a burned car used as a roadblock during a police operation against alleged drug traffickers in the Complexo ...

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their tumours.

VISALIA, Calif (KFSN) -- For the first time in over a decade, obesity rates in the US are down, from 39% to 37.7%. Meanwhile, ...

FDA restricts fluoride-based drugs for children after studies raise concerns about safety, side effects, and long-term health risks.

Viridian Therapeutics recently announced a royalty financing agreement with DRI Healthcare Trust, potentially unlocking up to US$300 million to support the commercial launch and development of ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular ...

Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older ...